WA-3 Western Australia 199919 Macrolides/Lincosamides Negative Community Increasing (ST5-IV) variable WA-2 Western Australia 2000 Macrolides/Lincosamides Negative Community Increasing ≤ (ST78-IV) [AGAR (variable) studies] WA-84 Victoria 2004 Fluoroquinolones Negative Community Increasing ≤ (ST45-V) [AGAR Macrolides/Lincosamides, studies] Tetracyclines (variable) USA300 United States 200023 Macrolides/Lincosamides Positive Community Rare and sporadic (ST8-IV) (2000)23 Fluoroquinolones (variable) *Staphylococcal Cassette Chromosome mec from †Apart β-lactams 2/3 designation refers to different pulsed field electrophoresis types. ‡The
WA-3 (ST5-IV) Western Australia 199919 Macrolides/Lincosamides variable Negative Community Increasing WA-2 (ST78-IV) Western Australia ≤ 2000 [AGAR studies] Macrolides/Lincosamides (variable) Negative Community Increasing WA-84 (ST45-V) Victoria ≤ 2004 [AGAR studies] Fluoroquinolones Macrolides/Lincosamides, Tetracyclines (variable) Negative Community Increasing USA300 (ST8-IV) United States (2000)23 200023 Macrolides/Lincosamides Fluoroquinolones (variable) Positive Community Rare and sporadic *Staphylococcal Cassette Chromosome mec †Apart from β-lactams ‡The 2/3 designation refers to different pulsed field electrophoresis types.
MRSA-A-Tale-of-Three-Types.docx